OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
7
Results
Show all
Save search
Copy query
Show results for
Unknown
(7)
Publication Date
Release Date
2023
(2)
2025
(1)
2022
(1)
2021
(1)
2018
(1)
2017
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Expanded autologous regulatory T-lymphocyte infusions in ALS: A phase I, first-in-human study.
Not available
S-EPMC5961523
|
biostudies-literature
Cite
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease.
Not available
S-EPMC10652426
|
biostudies-literature
Cite
Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis.
Not available
S-EPMC5901081
|
biostudies-literature
Cite
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis.
Not available
S-EPMC9423710
|
biostudies-literature
Cite
Detection of endothelial cell-associated human DNA reveals transplanted human bone marrow stem cell engraftment into CNS capillaries of ALS mice.
Not available
S-EPMC7990719
|
biostudies-literature
Cite
Fixel-Based Analysis of Diffusion Imaging as a Quantitative Marker of Disease State in Spinocerebellar Ataxia.
Not available
S-EPMC12455865
|
biostudies-literature
Cite
Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3.
Not available
S-EPMC10261544
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets